Platelet-activating_JJ
factor_NN
induces_VBZ
phospholipid_JJ
turnover_NN
,_,
calcium_NN
flux_NN
,_,
arachidonic_JJ
acid_NN
liberation_NN
,_,
eicosanoid_NN
generation_NN
,_,
and_CC
oncogene_NN
expression_NN
in_IN
a_DT
human_JJ
B_NN
cell_NN
line_NN
._.

Platelet-activating_JJ
factor_NN
is_VBZ
a_DT
potent_JJ
mediator_NN
of_IN
the_DT
inflammatory_JJ
response_NN
._.

Studies_NNS
of_IN
the_DT
actions_NNS
of_IN
platelet-activating_JJ
factor_NN
have_VBP
centered_VBN
mainly_RB
around_IN
neutrophils_NNS
,_,
monocytes_NNS
,_,
and_CC
platelets_NNS
._.

In_IN
this_DT
report_NN
we_PRP
begin_VBP
to_TO
uncover_VB
the_DT
influence_NN
of_IN
platelet-activating_JJ
factor_NN
on_IN
B_NN
lymphocytes_NNS
._.

Employing_VBG
the_DT
EBV-transformed_JJ
human_JJ
B_NN
cell_NN
line_NN
SKW6_NN
.4_CD
,_,
we_PRP
demonstrate_VBP
that_IN
platelet-activating_JJ
factor_NN
significantly_RB
alters_VBZ
membrane_NN
phospholipid_JJ
metabolism_NN
indicated_VBN
by_IN
the_DT
incorporation_NN
of_IN
32P_NN
into_IN
phosphatidylcholine_NN
,_,
phosphatidylinositol_NN
,_,
and_CC
phosphatidic_JJ
acid_NN
but_CC
not_RB
significantly_RB
into_IN
phosphatidylethanolamine_NN
at_IN
concentrations_NNS
ranging_VBG
from_IN
10_CD
-LRB-_-LRB-
-9_CD
-RRB-_-RRB-
to_TO
10_CD
-LRB-_-LRB-
-6_CD
-RRB-_-RRB-
M_NN
._.

The_DT
inactive_JJ
precursor_NN
,_,
lyso-platelet-activating_JJ
factor_NN
,_,
at_IN
a_DT
concentration_NN
as_RB
high_JJ
as_IN
10_CD
-LRB-_-LRB-
-7_CD
-RRB-_-RRB-
M_NN
had_VBD
no_DT
effect_NN
on_IN
any_DT
of_IN
the_DT
membrane_NN
phospholipids_NNS
._.

We_PRP
also_RB
show_VBP
that_IN
platelet-activating_JJ
factor_NN
from_IN
10_CD
-LRB-_-LRB-
-12_CD
-RRB-_-RRB-
to_TO
10_CD
-LRB-_-LRB-
-6_CD
-RRB-_-RRB-
M_NN
induced_VBD
rapid_JJ
and_CC
significant_JJ
elevation_NN
in_IN
intracellular_JJ
calcium_NN
levels_NNS
,_,
whereas_IN
lyso-platelet-activating_JJ
factor_NN
was_VBD
again_RB
ineffective_JJ
._.

We_PRP
further_RB
demonstrate_VBP
the_DT
impact_NN
of_IN
platelet-activating_JJ
factor_NN
binding_NN
to_TO
B_NN
cells_NNS
by_IN
measuring_VBG
platelet-activating_JJ
factor_NN
induced_VBN
arachidonic_JJ
acid_NN
release_NN
and_CC
5-hydroxyeicosatetraenoic_JJ
acid_NN
production_NN
._.

Moreover_RB
,_,
platelet-activating_JJ
factor_NN
was_VBD
capable_JJ
of_IN
inducing_VBG
transcription_NN
of_IN
the_DT
nuclear_JJ
proto-oncogenes_NNS
c-fos_NN
and_CC
c-jun_NN
._.

Finally_RB
we_PRP
explored_VBD
the_DT
possible_JJ
role_NN
of_IN
5-hydroxyeicosatetraenoic_JJ
acid_NN
as_IN
a_DT
regulator_NN
of_IN
arachidonic_JJ
acid_NN
liberation_NN
demonstrating_VBG
that_IN
endogenous_JJ
5-lipoxygenase_NN
activity_NN
modulates_VBZ
platelet-activating_JJ
factor_NN
induced_VBN
arachidonic_JJ
acid_NN
release_NN
perhaps_RB
acting_VBG
at_IN
the_DT
level_NN
of_IN
phospholipase_NN
A2_NN
._.

In_IN
summary_NN
,_,
platelet-activating_JJ
factor_NN
is_VBZ
shown_VBN
here_RB
to_TO
have_VB
a_DT
direct_JJ
and_CC
profound_JJ
effect_NN
on_IN
a_DT
pure_JJ
B_NN
cell_NN
line_NN
._.

